Evidence map›Paper›PMID 41356468›Full record

ArticleFrontiers in microbiology2025

Genetically engineered

Runyu Yang, Yitong Shi, Jinyu Bian, Mengxiao Sun, Junchi Ma, Cailing Ren, Xueyan Feng, Yun Wang, Yuanhui Yang, Jianqiang Zhou and 2 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Runyu YangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Yitong ShiJiaBioSyn (Shanghai) Biotechnology Co., Ltd, Shanghai, China.
Jinyu BianJiaBioSyn (Shanghai) Biotechnology Co., Ltd, Shanghai, China.
Mengxiao SunJiaBioSyn (Shanghai) Biotechnology Co., Ltd, Shanghai, China.
Junchi MaState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Cailing RenState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Xueyan FengState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Yun WangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Yuanhui YangShanghai Wenxin Biotechnology Co., Ltd., Shanghai, China.
Jianqiang ZhouJiaBioSyn (Shanghai) Biotechnology Co., Ltd, Shanghai, China.
Jun FuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Ruijuan LiState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rhamnolipids are valuable biosurfactants, but their large-scale application is limited by high production costs. Waste frying oil (WFO), a low-cost and abundant triglyceride-rich byproduct, offers a sustainable carbon source for rhamnolipid synthesis, though its utilization efficiency by microbes like Methods: This study evaluated the potential of engineered Results: Wild-type PAO1 and PAO1ΔaroA could synthesize rhamnolipids from WFO, while PAO1-RhlAB improved yields vs. PAO1 in WFO. Exogenous lipase addition (PAO1+) achieved 14.0 g/L rhamnolipids at 48 h (vs. 9 g/L for PAO1), and the synergistic PAO1-lipase+ reached 16.0 g/L (vs. 12.8 g/L for PAO1-lipase) at the same time. At 144 h, PAO1-lipase+ had the highest oil degradation rate (34.40%), while PAO1+ maintained a slightly higher yield (20 g/L) than PAO1-lipase+ (19 g/L). Discussion: These findings confirm that lipase regulation (overexpression or exogenous addition) enhances WFO utilization and rhamnolipid production, providing a cost-effective approach for sustainable rhamnolipid biosynthesis from waste lipids.

Indexed as

fermentationgenetic engineeringlipasePseudomonas aeruginosarhamnolipidswaste frying oil

Identifiers

PMID41356468
PMCPMC12676701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.